马来酸非戈替尼，CAS 登记号 1802998-75-9，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 马来酸非戈替尼 的 CAS 号：1802998-75-9，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Filgotinib maleate · CAS 1802998-75-9 · C25H27N5O7S. UNII JG8OB4UL9Y.
| CAS Registry Number | 1802998-75-9 |
|---|---|
| PubChem CID | 131801100 |
| Molecular formula | C25H27N5O7S |
| IUPAC name | (Z)-but-2-enedioic acid;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide |
| UNII (FDA) | JG8OB4UL9Y |
| Molecular Weight | 541.6 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 541.16311939 |
| Monoisotopic Mass | 541.16311939 |
| Topological Polar Surface Area | 180 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 834 |
| Reported hazard statements | H360 (100%), H373 (100%) |
|---|
H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
Filgotinib maleate; 1802998-75-9; JG8OB4UL9Y; Filgotinib maleate [USAN]; GS-6034; FILGOTINIB MALEATE [JAN]; FILGOTINIB MALEATE [WHO-DD]; RefChem:599201; Filgotinib (maleate); Jyseleca (TN); GLPG0634 maleate; Filgotinib maleate [MI]; UNII-JG8OB4UL9Y; EX-A741A; orb1686221; CHEMBL4298167
CAS 1802998-75-9; molecular formula C25H27N5O7S; molecular weight — g/mol.
Filgotinib maleate, 1802998-75-9, JG8OB4UL9Y, Filgotinib maleate [USAN], GS-6034, FILGOTINIB MALEATE [JAN].
Hazard statements reported: H360, H373.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.